Cerebellar high-grade gliomas do not present the same molecular alterations as supratentorial high-grade gliomas and may show histone H3 gene mutations

被引:13
|
作者
Tauziede-Espariat, Arnault [1 ]
Saffroy, Raphael [2 ]
Pages, Melanie [1 ]
Pallud, Johan [3 ,4 ,5 ]
Legrand, Laurence [6 ]
Besnard, Aurore [1 ]
Lacombe, Joelle [1 ]
Lot, Guillaume [7 ]
Borha, Alin [8 ]
Tazi, Sanaa [9 ]
Adle-Biassette, Homa [10 ]
Polivka, Marc [10 ]
Lechapt, Emmanuele [1 ,11 ]
Varlet, Pascale [1 ]
机构
[1] St Anne Hosp, Dept Neuropathol, 1 Rue Cabanis, F-75014 Paris, France
[2] Hop Paul Brousse, Dept Biochem & Oncogenet, Villejuif, France
[3] St Anne Hosp, Dept Neurosurg, Paris, France
[4] Paris Descartes Univ, Sorbonne Paris Cite, Paris, France
[5] Ctr Psychiatrie & Neurosci, IMA Brain, INSERM, U894, Paris, France
[6] St Anne Hosp, Dept Radiol, Paris, France
[7] Rothschild Fdn, Dept Neurosurg, Paris, France
[8] Cote Nacre Hosp, Dept Neurosurg, Caen, France
[9] Mondor Hosp, Dept Neurosurg, Creteil, France
[10] Lariboisiere Hosp, AP HP, Dept Pathol, Paris, France
[11] Cote Nacre Hosp, Dept Pathol, Caen, France
关键词
glioblastoma; cerebellum; histones; REPAIR DEFICIENCY SYNDROME; GLIOBLASTOMA-MULTIFORME; K27M MUTATIONS; TUMORS; H3F3A; SUBGROUPS; LYMPHOMA; ATRX; P16;
D O I
10.5414/NP301104
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Numerous molecular alterations have been described in supratentorial high-grade gliomas (1p19q co-deletion, IDHI/2, histone H3, hTERT promotor mutations, loss of ATRX) which have led to a new histomolecular classification of diffuse gliomas. We aimed at describing these alterations in a series of 19 adults with pure cerebellar high-grade gliomas. Systematic immunohistochemical analyses, including that of IDHIR132H, ATRX, p53, PTEN, EGFR, p16, FGFR3, BRAFV600E, mismatch repair proteins, H3K27me3, H3K36me3. and H3K27M; molecular analyses of IDH1/2. hTERT, BRAF, H3F3A, and HIST1H3B mutation hotspots: and EGFR, PTEN FISH were retrospectively performed in a multicentric study. We histopathologically identified 14 glioblastomas, 4 grade III astrocytomas and 1 gliosarcoma. Two cases showed a H3F3A K27M mutation. Only one case harbored a classical profile of glioblastoma with hTERT mutation, EGFR gain and 10q loss. The most frequent alteration was the absence of p16 immunoexpression We report a histomolecular analysis of pure cerebellar high grade gliomas. The histomolecular profile appears to be different from that of supratentorial gliomas, with no IDH1/2 gene mutations and only 1 case with a classic profile of de novo glioblastoma. In 2 cases, we identified H3F3A K27M mutation, classically described in pediatric midline gliomas.
引用
收藏
页码:209 / 216
页数:8
相关论文
共 50 条
  • [41] Radiation and Immunotherapy in High-grade Gliomas Where Do We Stand?
    Reznik, Elizabeth
    Smith, Andrew W.
    Taube, Shoshana
    Mann, Justin
    Yondorf, Menachem Z.
    Parashar, Bhupesh
    Wernicke, A. Gabriella
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (02): : 197 - 212
  • [42] Radiomics Can Distinguish Pediatric Supratentorial Embryonal Tumors, High-Grade Gliomas, and Ependymomas
    Zhang, M.
    Tam, L.
    Wright, J.
    Mohammadzadeh, M.
    Han, M.
    Chen, E.
    Wagner, M.
    Nemalka, J.
    Lai, H.
    Eghbal, A.
    Ho, C. Y.
    Lober, R. M.
    Cheshier, S. H.
    Vitanza, N. A.
    Grant, G. A.
    Prolo, L. M.
    Yeom, K. W.
    Jaju, A.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2022, : 603 - 610
  • [43] Molecular biology of high-grade gliomas: what should the clinician know?
    Silvia Hofer
    Elisabeth Rushing
    Matthias Preusser
    Christine Marosi
    ChineseJournalofCancer, 2014, 33 (01) : 4 - 7
  • [44] Against the Resilience of High-Grade Gliomas: Gene Therapies (Part II)
    Lucifero, Alice Giotta
    Luzzi, Sabino
    BRAIN SCIENCES, 2021, 11 (08)
  • [45] Valproic Acid May Be Tested in Patients With H3F3A-Mutated High-Grade Gliomas
    Felix, Francisco
    Fontenele, Juvenia
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3104 - +
  • [46] Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives
    Ceglie, Giulia
    Vinci, Maria
    Carai, Andrea
    Rossi, Sabrina
    Colafati, Giovanna Stefania
    Cacchione, Antonella
    Tornesello, Assunta
    Miele, Evelina
    Locatelli, Franco
    Mastronuzzi, Angela
    DIAGNOSTICS, 2020, 10 (09)
  • [47] Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
    Di Ruscio, Valentina
    Carai, Andrea
    Del Baldo, Giada
    Vinci, Maria
    Cacchione, Antonella
    Miele, Evelina
    Rossi, Sabrina
    Antonelli, Manila
    Barresi, Sabina
    Caulo, Massimo
    Colafati, Giovanna Stefania
    Mastronuzzi, Angela
    DIAGNOSTICS, 2022, 12 (02)
  • [48] INFRATENTORIAL HIGH-GRADE GLIOMAS: NEUROSURGICAL CASE SERIES WITH MOLECULAR ANALYSIS
    Stopa, Brittany
    Truman, Kyla
    Villa, Genaro
    Peruzzi, Pierpaolo
    Gormley, William
    Iorgulescu, Bryan
    Smith, Timothy
    NEURO-ONCOLOGY, 2021, 23 : 116 - 116
  • [49] Molecular biology of high-grade gliomas: what should the clinician know?
    Hofer, Silvia
    Rushing, Elisabeth
    Preusser, Matthias
    Marosi, Christine
    CHINESE JOURNAL OF CANCER, 2014, 33 (01) : 4 - 7
  • [50] Inactivating MUTYH germline mutations in pediatric patients with high-grade midline gliomas
    Kline, Cassie N.
    Joseph, Nancy M.
    Grenert, James P.
    van Ziffle, Jessica
    Yeh, Iwei
    Bastian, Boris C.
    Mueller, Sabine
    Solomon, David A.
    NEURO-ONCOLOGY, 2016, 18 (05) : 752 - 753